TO · Healthcare

Knight Therapeutics Inc. (GUD)

Drug Manufacturers - Specialty & Generic

Knight Therapeutics Inc. (GUD) is listed on TO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GUD

P/E ratio

18.00

Knight Therapeutics Inc. (GUD) — FAQ

What is GUD's P/E ratio?

The price-to-earnings (P/E) ratio for Knight Therapeutics Inc. (GUD) is 18.00 (data as of 2026-05-24).

Does Knight Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Knight Therapeutics Inc. (GUD). Check the MyAverix Finance app for the latest dividend data.

What sector is Knight Therapeutics Inc. in?

Knight Therapeutics Inc. (GUD) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is GUD listed on?

GUD is listed on TO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)